Therapeutic potential of icatibant (HOE-140, JE-049)

Author： Cruden Nicholas LM   Newby David E  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.13, 2008-09, pp. : 2383-2390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Icatibant: HOE 140, JE 049, JE049

By Adis International Limited  

Drugs in R&D, Vol. 6, Iss. 4, 2005-01 ,pp. : 239-244

Adis International

Access to resources Recommend Favorite

Icatibant: HOE 140, JE 049, JE049

By Adis International Limited  

Drugs in R&D, Vol. 5, Iss. 6, 2004-01 ,pp. : 343-348

Adis International

Access to resources Recommend Favorite

The bradykinin B 2 receptor antagonist Icatibant (HOE 140) corrects avid Na + retention in rats with CCl 4 -induced liver cirrhosis: possible role of enhanced microvascular leakage

By Wirth K.J.   Bickel M.   Hropot M.   Gunzler V.   Heitsch H.   Ruppert D.   Scholkens B.A.  

European Journal of Pharmacology, Vol. 337, Iss. 1, 1997-10 ,pp. : 45-53

Elsevier

Access to resources Recommend Favorite

Icatibant

By Deeks Emma D.  

Drugs, Vol. 70, Iss. 1, 2010-01 ,pp. : 73-81

Adis International

Access to resources Recommend Favorite

Ala scan analogues of HOE 140. Synthesis and biological activities

By Quartara L.   Ricci R.   Meini S.   Patacchini R.   Giolitti A.   Amadesi S.   Rizzi C.   Rizzi A.   Varani K.   Borea P.A.   A. Maggi C.   Regoli D.  

European Journal of Medicinal Chemistry, Vol. 35, Iss. 11, 2000-11 ,pp. : 1001-1010

Elsevier

Access to resources Recommend Favorite